ArticleNanomaterials (Basel, Switzerland)2020
Biological Safety and Biodistribution of Chitosan Nanoparticles.
Abstract read
In one paragraph
Article in Nanomaterials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.
0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed.
- Chitosan in Modern Pharmacotherapy: Chitosan Nanoparticles and Delivery Systems.Pharmaceutics · 2026Review
- Chitosan-protected dsRNA increases efficacy against Helicoverpa armigera without compromising biosafety for pollinators.Pest management science · 2026Article
- Exploration of miR-326 delivery via biocompatible polymeric nanoparticles in medulloblastoma: A preliminary study.Molecular therapy. Nucleic acids · 2026Article
- Chitosan Nanoparticles Unlock the Antioxidant Potential of Epigallocatechin Gallate in Pancreatic and Hepatic Cancer Cell Models.ACS omega · 2026Article
- Physico-biochemical Properties of Chitosan-poly(ACS omega · 2025Article
- Chitosan Nanoparticles Enhance the Antiproliferative Effect of Lapachol in Urothelial Carcinoma Cell Lines.Pharmaceutics · 2025Article
- Impacts ofToxicology research · 2025Article
- Chitosan Nanoparticles: Approaches to Preparation, Key Properties, Drug Delivery Systems, and Developments in Therapeutic Efficacy.AAPS PharmSciTech · 2025Review
- Nanoparticle Formulations for Intracellular Delivery in Colorectal Cancer Therapy.AAPS PharmSciTech · 2025Article
- Review
- Development, Characterization, and Evaluation of Chi-Tn mAb-Functionalized DOTAP-PLGA Hybrid Nanoparticles Loaded with Docetaxel for Lung Cancer Therapy.Pharmaceutics · 2025Article
- CpG oligodeoxynucleotide-coated chitosan nanoparticles enhance macrophage proinflammatory phenotype in vitro.Clinical and experimental immunology · 2025Article
- Shifting cold to hot tumors by nanoparticle-loaded drugs and products.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025Review
- Unlocking ginsenosides' therapeutic power with polymer-based delivery systems: current applications and future perspectives.Frontiers in pharmacology · 2025Review
- Precision Nanomedicine: Lapatinib-Loaded Chitosan-Gold Nanoparticles Targeting LINC01615 for Lung Cancer Therapy.The AAPS journal · 2024Article
- Optimization, physicochemical stability and in vivo study of alginate-chitosan composites as nanocarriers for low molecular weight angiotensin I-converting enzyme (ACE)-inhibitory peptide.Journal of food and drug analysis · 2024Article
- Nano-Formulations of Natural Antioxidants for the Treatment of Liver Cancer.Biomolecules · 2024Review
- Comparative biotoxicity study for identifying better alternative insecticide especially green nano-emulsion which used as mosquitocides.BMC veterinary research · 2024Article
- Hedgehog signaling is a promising target for the treatment of hepatic fibrogenesis: a new management strategy using itraconazole-loaded nanoparticles.Frontiers in pharmacology · 2024Article
- Research and Application of Chitosan Nanoparticles in Orthopedic Infections.International journal of nanomedicine · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Dmitry SoninAlmazov National Medical Research Centre, Institute of Experimental Medicine, 2 Akkuratova str., 197341 Saint Petersburg, Russia.
Evgeniia PochkaevaPeter the Great Saint Petersburg Polytechnic University, Graduate School of Biotechnology and Food Science, 29 Polytechnicheskaya str., 195251 Saint Petersburg, Russia.
Sergei ZhuravskiiAlmazov National Medical Research Centre, Institute of Experimental Medicine, 2 Akkuratova str., 197341 Saint Petersburg, Russia.
Viktor PostnovAlmazov National Medical Research Centre, Institute of Experimental Medicine, 2 Akkuratova str., 197341 Saint Petersburg, Russia.
Dmitry KorolevAlmazov National Medical Research Centre, Institute of Experimental Medicine, 2 Akkuratova str., 197341 Saint Petersburg, Russia.
Lyubov VasinaAlmazov National Medical Research Centre, Institute of Experimental Medicine, 2 Akkuratova str., 197341 Saint Petersburg, Russia.
Daria KostinaAlmazov National Medical Research Centre, Institute of Experimental Medicine, 2 Akkuratova str., 197341 Saint Petersburg, Russia.
Daria MukhametdinovaAlmazov National Medical Research Centre, Institute of Experimental Medicine, 2 Akkuratova str., 197341 Saint Petersburg, Russia.
Irina ZelinskayaAlmazov National Medical Research Centre, Institute of Experimental Medicine, 2 Akkuratova str., 197341 Saint Petersburg, Russia.
Yury SkorikAlmazov National Medical Research Centre, Institute of Experimental Medicine, 2 Akkuratova str., 197341 Saint Petersburg, Russia.
Elena NaumyshevaAlmazov National Medical Research Centre, Institute of Experimental Medicine, 2 Akkuratova str., 197341 Saint Petersburg, Russia.
Anna MalashichevaAlmazov National Medical Research Centre, Institute of Experimental Medicine, 2 Akkuratova str., 197341 Saint Petersburg, Russia.
Pavel SomovTESCAN (CIS) Ltd., 11 Grazhdansky ave., 195220 Saint Petersburg, Russia.
Maria IstominaAlmazov National Medical Research Centre, Institute of Experimental Medicine, 2 Akkuratova str., 197341 Saint Petersburg, Russia.
Natalia RubanovaAlmazov National Medical Research Centre, Institute of Experimental Medicine, 2 Akkuratova str., 197341 Saint Petersburg, Russia.
Ilia AleksandrovAlmazov National Medical Research Centre, Institute of Experimental Medicine, 2 Akkuratova str., 197341 Saint Petersburg, Russia.
Marina VasyutinaAlmazov National Medical Research Centre, Institute of Experimental Medicine, 2 Akkuratova str., 197341 Saint Petersburg, Russia.
Michael GalagudzaITMO University, Laboratory of Digital and Display Holography, 49 Kronverksky ave., 197101 Saint Petersburg, Russia.
Funding
Government of Russian Federation 08-08Russian Science Foundation 14-15-00473
Abstract
PubMed holds no abstract for this paper.
Indexed as
biodistributionblood compatibilitychitosanin vivo treatmentpolymer nanoparticlessafety evaluation
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.